17 March 2025 - BEAM ALLIANCEPublication of the 3rd edition of the beAMRometerBeyond the figures, there is a palpable sense of frustration. The frustration of having good technology and not being able…
6 February 2025 - BEAM ALLIANCEJoin us at the AMR conference!The AMR Conference is 2 days of updates on the latest developments in the fight against microbial resistance, from a…
26 September 2024 - BEAM ALLIANCENew York, From inside the UN buildings – Remko van LeeuwenJust a few hours ago the General Assembly of the UN has adopted a new declaration on fighting AMR. Regardless…
17 September 2024 - BEAM ALLIANCEGeneral Pharmaceutical Legislation Revision: Taking Stock of the EU Parliament Position and Moving ForwardThe BEAM Alliance would like to reiterate its call for optimal PULL incentives designed to fit innovators’ needs based on…
24 October 2023 - BEAM ALLIANCEBEAM Alliance shares its views on the ongoing revision of the General Pharmaceutical LegislationWe call on policymakers to stop postponing decisions and either propose a clear incentive package now or reintroduce the TEE…
5 September 2023 - BEAM ALLIANCEBEAM Alliance is Launching a new Task Force to address Issues from the AMR Diagnostics SegmentThe new Task Force is gathering innovative SMEs operating in the AMR field and external experts.
19 March 2025 - BioVersysBioVersys: First ever patient dosed with alpibectir-ethionamide in combination with first-line TB drugs in a 14-day phase 2 clinical trialTuberculosis remains the largest infectious disease killer in the world and is far from being eradicated. Our partnership with GSK,…
14 March 2025 - Basilea Pharmaceutica InternationalStrong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to BasileaWe are pleased with the strong sales performance from our partner Pfizer, resulting in this first sales milestone for the…
11 March 2025 - QureTech BioQureTech Bio granted European patent for new class of antibacterialsThe patent ensures strong protection for GmPcides, which is crucial in our industry, and marks an important step in making…
4 March 2025 - Centauri TherapeuticsCentauri Therapeutics selects first clinical candidate, for immunotherapeutic treatment of Gram-negative bacterial infectionsWe are excited to enter the clinical development phase with the ABX-01 lead candidate, thanks to our dedicated team who…
25 February 2025 - Infex Therapeuticslnfex signs exclusive license agreement with Venus Remedies Ltd to advance MET-X through clinical development and commercialisation in lndiaMET-X has shown best-in-class performance in preclinical studies and could be a game-changing treatment for those suffering from Gram negative…
25 February 2025 - Rime BioinformaticsHigh-Performance Genome Annotation for a Safer and Faster-Developing Phage TherapyThis article is dealing with phage genome annotation and its impact on phage therapy. Our study compares manual annotation (SEA-PHAGES)…
3 March 202610th AMR ConferenceSave the date! The 10th AMR Conference will be organized as a face-to-face event on 3-4 March 2026, in Basel.…
3 April 2025REVIVE Webinar: Charting new frontiers in artificial intelligence for antibiotic designThis live webinar including an interactive Q&A session will be broadcast on 3 April 2025 at 17:00-18:30 CEST.
28 March 2025GARDP Webinar – Cefiderocol access project: Where are we now?This live webinar including an interactive Q&A session will be broadcast on 28 March 2025 at 15:00-16:15 CET.
17 March 2025BIO-Europe Spring® 2025 – 19th Annual International Partnering ConferenceBIO-Europe Spring will bring together over 3,700 leading executives from around the world. Specifically, we will host more than 20,000…
27 February 2025REVIVE Webinar: In vitro and in vivo correlations for prediction of human pharmacokinetics and dose of antimicrobialsThis live webinar including an interactive Q&A session will be broadcast on 27 February 2025 at 17:00-18:30 CET.
25 February 20259th AMR ConferenceSave the date! The 9th AMR Conference will be organized as a face-to-face event on 25-26 February 2025, in Basel.…